Navigating the Genetic Frontier: Establishing Genetic Clinics for Comprehensive Hereditary Cancer Management in Resource-Limited Settings

Abstract

This review article explores the vital role of genetic clinics in the management of hereditary cancers, emphasizing their significance in early detection, tailored treatment, and family screening. It presents analysis of the prevalence of hereditary cancers in India, including breast, ovarian, prostate, colon, and kidney cancers, stressing the necessity for effective genetic testing and counseling services.

The manuscript synthesizes available prevalence data, outlines key components and challenges of clinic establishment, and provides strategies for improving public acceptance, access, and workforce capacity. It also focuses on importance of early detection, family screening, and targeted therapies for patients with inherited genetic mutation.

In conclusion, the article emphasizes the need for a patient-centered approach, increased access to genetic clinics, exploration of future genomics and technology advancements, and the evaluation of genetic clinics' impact on patient outcomes. By addressing challenges and capitalizing on opportunities, genetic clinics can continue to improve patients' and their families' lives, ultimately contributing to the battle against hereditary cancers.

Keywords

genetic clinics - hereditary cancers - genetic testing and counselling - cancer prevention and management - awareness and acceptance

Data Availability Statement

Data sharing is not applicable to this article as no new data were created or analyzed in this study

Patient Consent

No patient data was collected as informed consent was not required.

Publication History

Article published online:
22 August 2025

• References

• 1 Sathishkumar K, Chaturvedi M, Das P, Stephen S, Mathur P. Cancer incidence estimates for 2022 & projection for 2025: result from National Cancer Registry Programme, India. Indian J Med Res 2022; 156 (4 & 5): 598-607
• 2 Hann KEJ, Freeman M, Fraser L. et al; PROMISE study team. Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: a systematic review. BMC Public Health 2017; 17 (01) 503
• 3 Kwong A, Tan DS, Ryu JM. ACROSS Consortium. Current practices and challenges in genetic testing and counseling for women with breast and ovarian cancer in Asia. Asia Pac J Clin Oncol 2025; 21 (02) 211-220
• 4 Sharma HS, Singh KP. Genetic clinic: need of the hour. J Med Soc. 2024; 38 (02) 83-84
• 5 Ledermann J, Harter P, Gourley C. et al. Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer. N Engl J Med 2012; 366 (15) 1382-1392
• 6 Ramos E. Genetic counseling, personalized medicine, and precision health. Cold Spring Harb Perspect Med 2020; 10 (09) a036699
• 7 Pederson HJ, Narod SA. Commentary: why is genetic testing underutilized worldwide? The case for hereditary breast cancer. BJC Rep 2024; 2 (01) 73
• 8 Litton G, Kane D, Clay G, Kruger P, Belnap T, Parkinson B. Multidisciplinary cancer care with a patient and physician satisfaction focus. J Oncol Pract 2010; 6 (06) e35-e37
• 9 White MT. Making sense of genetic uncertainty: the role of religion and spirituality. Am J Med Genet C Semin Med Genet 2009; 151C (01) 68-76
• 10 Moore RA, Matthews AL, Cohen L. How might the genetics profession better utilize social media. J Genet Couns 2018; 27 (02) 493-504
• 11 Melhem SJ, Nabhani-Gebara S, Kayyali R. Leveraging e-health for enhanced cancer care service models in middle-income contexts: qualitative insights from oncology care providers. Digit Health 2024; 10: 20 552076241237668
• 12 Wang Y, He Y, Shi Y. et al. Aspiring toward equitable benefits from genomic advances to individuals of ancestrally diverse backgrounds. Am J Hum Genet 2024; 111 (05) 809-824